Join UBNS and Atlas Surgery Center for the inaugural Buffalo Brains in Motion Brain Aneurysm Awareness Run & Walk

REGISTER TODAY

Contact Dr. Levy and his team for a trusted second opinion on your AVM or aneurysm diagnosis.

LEARN MORE
MENU

Doppler Testing

UBNS provides in-house Carotid Doppler testing for vascular disease to save our patients the inconvenience of having to travel elsewhere for their imaging studies.  Carotid Doppler is a safe, painless, and noninvasive ultrasound test used to monitor blood flow from the carotid arteries to the brain. Doppler images help physicians determine whether blood flow to the brain has been compromised by narrowed blood vessels due to plaque buildup.  Evidence of extensive carotid narrowing may lead to a diagnosis of carotid artery disease (CAD)—a major risk factor for stroke.

Stroke, the third leading cause of death in the United States, occurs as a result of CAD when blood clots or dislodged plaque block the narrowed carotid artery, thereby interrupting blood flow to the brain.  Carotid Doppler can detect CAD before a stroke occurs to determine if measures should be taken to prevent future stroke. If indicated, patients may undergo a minimally invasive carotid stenting procedure to widen the blocked artery and capture any dislodged plaque.

WNY Locations

  • Buffalo General Medical Center

Surgical Locations:  Sisters of Charity Hospital, Niagara Falls Memorial Medical Center, Millard Fillmore Suburban Hospital, Mercy Hospital of Buffalo, Buffalo General Medical Center, Gates Vascular Institute, Kenmore Mercy Hospital

Follow along with us

Publications | August 4, 2026

View all Publications Small Blue Arrow Icon

Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome

In the News | July 29, 2026

UBNS in the News Blue Arrow Icon

UBNS Activated as Local Research Site for SynchronBCI INTENT Study

UBNS has been activated as a local research site for a new study by Synchron, a U.S. neurotechnology company, in an effort to restore autonomy in people's lives who are affected by degenerative diseases, such...

Continue to news article

UBNS Residency Program

Follow doctors